Pharmacists help patients overcome barriers that can delay or disrupt treatment. Access challenges such as prior authorizations, coverage requirements and affordability concerns can stand between ...

ASHP Midyear Clinical Meeting & Exhibition 2026 takes place December 6-9, 2026 in Orlando, Florida. Visit McKesson at booth #217 to connect with our health system pharmacy experts. Listen to the ...

The Health Mart Postgraduate Year One (PGY1) Community-based Pharmacy Residency Program provides advanced training that helps pharmacists accelerate their development. Residents gain experience across ...

Consolidated revenues of $111.0 billion increased 8%. Earnings per diluted share of $10.44 increased $1.52. Adjusted Earnings per Diluted Share of $11.68 increased 18%. Generated $3.1 billion of cash ...

Launched in 2017, MIPS provides annual payment incentives or penalties to eligible providers (EPs) beginning in 2019. McKesson has received approval from CMS to participate in the MIPS 2026 year as a ...

These efforts reflect a shared commitment to apply AI thoughtfully to reduce complexity and strengthen the systems patients rely on. The healthcare system’s intricate web of tasks and processes often ...

Oncologists are treating nearly twice as many patients with cell and gene therapies (CGTs) as they were in 2024, and 97% say CGTs could offer some patients the best chance for a cure. This year, the ...

Biologics by McKesson combines technology, clinical expertise and personalized support to help patients access and understand increasingly complex specialty therapies. This Always Advancing episode ...

Approve, download and pay all pharmaceutical product purchases with the payables management module in the McKesson Connect online ordering platform for pharmacies. View, approve, download, print and ...

McKesson is investigating a cybersecurity incident involving third-party applications and unauthorized access and exfiltration of data. McKesson supplies medical equipment, pharmaceuticals, and health ...

Consolidated revenues of $97.8 billion increased 23%. Earnings per diluted share of $6.25 decreased $0.75. Adjusted Earnings per Diluted Share of $8.26 increased 5%. McKesson completed the ...

IRVING, Texas, August 26, 2024—McKesson Corporation (NYSE: MCK) announced today that it signed a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise ...